Sponsor:
Psoriasis Treatment Center of Central New Jersey
Code:
NCT06745999
Conditions
Actinic Keratoses
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ameluz 10% Topical Gel
Red Light PDT
Cryotherapy
Brief summary:
Conditions
Actinic Keratoses
Study ID
NCT06745999
Start date
May 3, 2023
Status verified date
Mar, 2024
Completion date
Jun, 2025
Anticipated
Primary completion date
May, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: cryotherapy followed by 10% ALA gel Red light PDT
experimental: 10% ALA gel Red Light PDT followed by cryotherapy
Interventions
Ameluz 10% Topical Gel
Red Light PDT
Cryotherapy
Primary outcome measure
Central contacts
Locations
Psoriasis Treatment Center of New Jersey
Recruiting
East Windsor, New Jersey, United States, 08520
Contacts
Sponsor
Psoriasis Treatment Center of Central New Jersey
Last update posted
Dec 24, 2024
Last verified
Mar, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Psoriasis Treatment Center of Central New Jersey on 2024-12-24.